Viewing Study NCT06848569


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2025-12-24 @ 10:57 PM
Study NCT ID: NCT06848569
Status: RECRUITING
Last Update Posted: 2025-02-27
First Post: 2025-02-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module